Special Issue "The 20th Anniversary of Pharmaceuticals—Metal-Based Drugs for Cancer Treatment, Antibacterial and Antiviral Applications"

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: 29 February 2024 | Viewed by 362

Special Issue Editors

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi, 13, 56124 Pisa, Italy
Interests: inorganic chemistry; medicinal chemistry; bioinorganic chemistry; mass spectrometry; metal-based drugs; gold-based compounds, platinum-based compounds; drug targeting and delivery strategies; DNA and protein interactions; anticancer therapies; drug repurposing
Special Issues, Collections and Topics in MDPI journals
Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi, 13, 56124 Pisa, Italy
Interests: bioinorganic chemistry; inorganic chemistry; NMR; metal-based drugs; chemotherapeutic agents
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Since the discovery of cisplatin in 1965 by Barnett Rosenberg, metal-based drugs have gained growing interest due to their great potential not only for the treatment of cancer, but also as effective bacterial and viral agents. The development of metal-based drugs with enhanced therapeutic properties has become a very active area of research. Metal-based drugs possess unique characteristics, such as chemical and structural diversity, high selectivity, and reactivity, which makes them promising for developing more effective treatments against a variety of diseases. They have been used to target cancer cells, bacteria, and viruses, either alone or in combination with other therapies. We invite authors to submit original research and review articles on the latest developments in metal-based compounds of medicinal interest. Topics of interest include, but are not limited to:     

  • The design, synthesis, and characterization of novel metal-based drugs;
  • The molecular mechanisms of action and resistance of metal-based drugs;   
  • Preclinical and clinical studies of metal-based compounds;      
  • Combinatorial approaches involving metallodrugs and other therapeutics;
  • Imaging and diagnostic applications of metal-based complexes. 

All submitted papers will undergo rigorous peer review by international experts in the field. The collection of accepted manuscripts will be published as a Special Issue in Pharmaceuticals, the 20th Anniversary series.

Dr. Alessandro Pratesi
Dr. Damiano Cirri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • metal-based drugs
  • anticancer compounds
  • antivirals
  • antibiotics
  • chemotherapy
  • drug targeting
  • delivery strategies
  • drug repurposing
  • medicinal chemistry
  • bioinorganic chemistry

Published Papers

This special issue is now open for submission.
Back to TopTop